Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar:169:32-34.
doi: 10.1016/j.maturitas.2023.01.002. Epub 2023 Jan 7.

Left bundle branch blocks do not predict mortality in oldest-old patients hospitalized for COVID-19: The GERIA-COVID cohort study

Adeline Bannier  1 , Joëlle Goldberg  2 , Marie Otekpo  2 , Jocelyne Loison  2 , Jennifer Gautier  2 , Cédric Annweiler  3 ; GERIA-COVID study group
Affiliations

Left bundle branch blocks do not predict mortality in oldest-old patients hospitalized for COVID-19: The GERIA-COVID cohort study

Adeline Bannier et al. Maturitas. 2023 Mar.

Abstract

This cohort study aimed to determine whether left bundle branch blocks (LBBB) in COVID-19 were associated with 28-day and 3-month mortality in oldest-old patients. LBBB were sought on electrocardiogram on hospital admission in patients aged 80 years or more admitted for COVID-19 to the geriatric acute care unit of Angers University Hospital, France, during the first wave of the pandemic. Eighty-five participants were included (mean ± SD, 88.3 ± 5.3 years; 48.2 % women; 14.1 % with LBBB; 18.8 % mortality after 28 days and 28.2 % after 3 months). LBBB was associated neither with 28-day (HR = 1.65, P = 0.58) nor with 3-month (HR = 1.08, P = 0.92) mortality, in fully-adjusted Cox regression.

Keywords: Aged; Bundle branch block; COVID-19; Intraventricular conduction disorders; Mortality; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Cédric Annweiler serves as an editor for Maturitas. All authors declare they do not have any other financial and personal competing interests with this paper.

References

    1. Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–793. - PubMed
    1. Bansal M. Cardiovascular disease and COVID-19. Diabetes. Metab. Syndr. 2020;14:247–250. - PMC - PubMed
    1. Long B., Brady W.J., Bridwell R.E., Ramzy M., Montrief T., Singh M., et al. Electrocardiographic manifestations of COVID-19. Am. J. Emerg. Med. 2021;41:96–103. - PMC - PubMed
    1. McAnulty J.H., Kauffman S., Murphy E., Kassebaum D.G., Rahimtoola S.H. Survival in patients with intraventricular conduction defects. Arch. Intern. Med. 1978;138:30–35. - PubMed
    1. Zhang Y., Coats A., Zheng Z. Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2020;22:941–956. - PubMed